Posts for Category: ACMT News
-
Keith K. Burkhart, MD, FACMT to Receive 2024 ACMT Career Achievement Award
Congratulations to 2024 ACMT Career Achievement Award recipient Keith K. Burkhart, MD, FACMT. Dr. Burkhart will present the 2023 Career Achievement Address at the 2024 ACMT Annual Scientific Meeting on April 13, 2024. -
ToxIC Joins Distinguished Universities and Research Institutes in Receiving FDA’s BAA Contract
ACMT/ToxIC’s “Real-world Examination of Naloxone for Drug Overdose Reversal (RENDOR)” project ranked second highest in funding amount. -
Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding
Under a U.S. Food and Drug Administration (FDA) contract with the American College of Medical Toxicology (ACMT), the Toxicology Investigators Consortium (ToxIC) is expanding its Drug Overdose Toxico-Surveillance (DOTS) Reporting Program evaluating patients with opioid and stimulant overdoses. -
Fentanyl, Xylazine, Cannabinoids to Feature in Virtual Forensic Toxicology Seminar December 14 – 15, 2023
“The 2023 Virtual Seminar in Forensic Toxicology: Expanding Worlds of Cannabinoids & Polydrug Exposures” is a two-day virtual seminar featuring distinguished industry experts addressing some of the most crucial topics affecting the medical and public health landscape today. Topics covered include cannabis and alternative cannabinoid impairment, and new research on medical legal death investigations involving polydrug exposures such as fentanyl, xylazine, benzodiazepines. -
Important Announcement: Postponement of Upcoming ACMT-Israeli Society of Toxicology Conference
With a heavy heart, the ACMT and Israeli organizers are compelled to postpone the conference to more peaceful times. Â -
Philadelphia Inquirer: We’re talking about fentanyl and xylazine all wrong
ACMT Member, Jeanmarie Perrone, MD, FACMT, penned this article. "Rather than stigmatizing people living with addiction, the most important thing we can do is encourage and support people in their journey to recovery." -
ACMT Activities at 2023 NACCT
It was inspiring to be able to connect with many of you in Montreal this past week ! We were excited to engage with colleagues, see new and familiar faces, and engage with everyone during this fantastic event. -
Out-of-Hospital Naloxone Administration to be Studied in New Federally-Funded Project
Under a U.S. Food and Drug Administration (FDA) contract awarded to the American College of Medical Toxicology’s (ACMT), the Toxicology Investigators Consortium (ToxIC) will examine the real-world administration of naloxone by community members, fire and police departments, and emergency medical services (EMS) personnel. -
ACMT/ToxIC Awarded 3 FDA Contracts
We are delighted to announce that ACMT has just received notice that we have been awarded three contracts from the FDA to support ToxIC's toxicosurveillance program for the coming year. -
In Memoriam: Christopher Linden, MD, FACMT
ACMT leadership was deeply saddened to hear of the recent passing of Christopher Linden, MD, FACMT. Our most sincere condolences go out to Dr. Linden's family and colleagues. Read more...